The identification of a recurrent mutation in the tyrosine kinase Janus kinase 2 (JAK2V617F) in most patients with primary myelofibrosis (PMF), polycythemia vera (PV) and essential thrombocythemia (ET) suggest a potential common main cause of disease development [2, 3]. The gene discussed is JAK2; the disease is essential thrombocythemia.